Published in Trials on September 29, 2017
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol (2003) 5.00
Public attitudes toward participation in cancer clinical trials. J Clin Oncol (2003) 4.41
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med (2004) 2.97
Therapeutic misconception in clinical research: frequency and risk factors. IRB (2004) 2.78
Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials (2010) 2.25
Therapeutic misconception in research subjects: development and validation of a measure. Clin Trials (2012) 1.92
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer (2010) 1.84
Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ (1999) 1.76
Attitudes towards clinical research amongst participants and nonparticipants. J Intern Med (2002) 1.74
Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect (1999) 1.62
Potential subjects' responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson's disease. J Clin Ethics (2012) 1.61
Ethical aspects of clinical trials: the attitudes of the public and out-patients. J Intern Med (1999) 1.56
Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clin Trials (2010) 1.40
Information and communication in the context of a clinical trial. Eur J Cancer (2000) 1.24
Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology (1999) 1.07
Two concepts of therapeutic optimism. J Med Ethics (2011) 1.02
Attitude towards clinical trials: results of a survey of persons interested in research. Inflamm Res (2004) 0.95
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception. J Med Ethics (2008) 0.92
Study design attributes influenced patients' willingness to participate in clinical research: a randomized vignette-based study. J Clin Epidemiol (2010) 0.90
Impact of placebo assignment in clinical trials of Parkinson's disease. Mov Disord (2003) 0.89
Development and initial validation of the Therapeutic Misunderstanding Scale for use with clinical trials research participants. Aging Ment Health (2011) 0.86
What motivates Parkinson's disease patients to enter clinical trials? Parkinsonism Relat Disord (2011) 0.84
Long term understanding of study information in research participants with Parkinson's disease. Parkinsonism Relat Disord (2009) 0.84
Sham surgery controls in Parkinson's disease clinical trials: views of participants. Mov Disord (2012) 0.83
Rising to the Challenges of Clinical Trial Improvement in Parkinson's Disease. J Parkinsons Dis (2015) 0.81
Attitudes and views of the general public towards research participation. Intern Med J (2013) 0.80
Patient attitudes to clinical trials: development of a questionnaire and results from asthma and cancer patients. Health Expect (2005) 0.79
The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: balancing hope and uncertainty. Trials (2016) 0.79
Parkinson's disease: recent advances. J Neurol (2014) 0.78
Geographical variation of medicated parkinsonism in Finland during 1995 to 2000. Mov Disord (2008) 0.77
Understanding the 'therapeutic misconception' from the research participant's perspective. J Med Ethics (2016) 0.77
Faith, Hope And (No) Clarity. J Med Ethics (2016) 0.77
Changing epidemiology of Parkinson's disease: predicted effects of levodopa treatment. Acta Neurol Scand (1979) 0.77
Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception? J Med Ethics (2016) 0.77
Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling. Epilepsy Behav (2015) 0.76
Investigating the informed consent process, therapeutic misconception and motivations of Egyptian research participants: a qualitative pilot study. East Mediterr Health J (2015) 0.76
How not to test the prevalence of therapeutic misconception. J Med Ethics (2016) 0.76
Factors associated with willingness to participate in clinical trials: a nationwide survey study. BMC Public Health (2015) 0.76
Could the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem? IRB (2015) 0.76
Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception? J Med Ethics (2014) 0.76
Parkinson's disease and insomnia. Neurol Sci (2015) 0.80
Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson's disease. J Parkinsons Dis (2014) 0.75